Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX
· Real-Time Price · USD
1.39
0.03 (2.21%)
At close: May 28, 2025, 3:59 PM
1.36
-1.72%
After-hours: May 28, 2025, 04:10 PM EDT
2.21% (1D)
Bid | 1.36 |
Market Cap | 59.4M |
Revenue (ttm) | -52.4M |
Net Income (ttm) | -127.89M |
EPS (ttm) | -3.02 |
PE Ratio (ttm) | -0.46 |
Forward PE | -0.85 |
Analyst | Buy |
Ask | 1.41 |
Volume | 115,843 |
Avg. Volume (20D) | 314,946 |
Open | 1.38 |
Previous Close | 1.36 |
Day's Range | 1.36 - 1.41 |
52-Week Range | 0.89 - 4.29 |
Beta | 0.84 |
About RPTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol RPTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for RPTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
-55.42%
Repare Therapeutics shares are trading lower after...
Unlock content with
Pro Subscription
7 months ago
+0%
Repare Therapeutics shares are trading higher after the company announced it will present its Phase 1 data highlighting Camonsertib in combination with radiotherapy treatment at the ASTRO annual meeting